Lipella Pharmaceuticals News

Maxim Group Maintains Lipella Pharmaceuticals(LIPO.US) With Buy Rating

Moomoo NewsNov 20 11:31 ET

Maxim Group Maintains Lipella Pharmaceuticals(LIPO.US) With Buy Rating, Maintains Target Price $2

Moomoo NewsSep 25 13:32 ET

Buy Rating on Lipella Pharmaceuticals Backed by Promising Phase 2a Results for Oral Lichen Planus Treatment

TipRanksSep 25 13:20 ET

Maxim Group Maintains Lipella Pharmaceuticals(LIPO.US) With Buy Rating, Maintains Target Price $2

Moomoo NewsAug 15 12:32 ET

Maxim Group Maintains Lipella Pharmaceuticals(LIPO.US) With Buy Rating, Maintains Target Price $2

Moomoo NewsAug 13 09:33 ET

Buy Rating Affirmed: Lipella Pharmaceuticals' Innovative Drug Delivery and Clinical Advancements Propel Optimism

TipRanksAug 13 08:51 ET

Maxim Group Maintains Lipella Pharmaceuticals(LIPO.US) With Buy Rating, Maintains Target Price $2

Moomoo NewsJul 30 10:31 ET

Buy Rating Affirmed for Lipella Pharmaceuticals on LP-310's Phase 2a Enrollment and Strategic Advantages

TipRanksJul 30 10:28 ET

Analysts Are Bullish on These Healthcare Stocks: Crinetics Pharmaceuticals (CRNX), Lipella Pharmaceuticals, Inc. (LIPO)

TipRanksMay 22 13:15 ET

Lipella Pharmaceuticals Analyst Ratings

BenzingaApr 9 11:37 ET